<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xia Y</submitter><funding>National Natural Science Foundation of China</funding><pagination>313</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7374834</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Small extracellular vesicles (sEV) secreted by mesenchymal stem cells (MSC) derived from human induced pluripotent stem cells (iPSC, iMSC-sEV) are considered to have great potential in treating ischemic diseases. Angiogenesis play an important role in post-stroke recovery. However, no studies have yet been conducted to systemically examine the effect and the underlying mechanism of iMSC-sEV on angiogenesis under brain ischemia conditions.&lt;h4>Methods&lt;/h4>Ischemic stroke model was performed in rats induced by middle cerebral artery occlusion (MCAO), and the pro-angiogenic capacity of iMSC-sEV was measured. The in vitro effects of iMSC-sEV on the migration and tube formation of endothelial cells were investigated, respectively. Autophagy and autophagy-related signaling path</pubmed_abstract><journal>Stem cell research &amp; therapy</journal><pubmed_title>Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke.</pubmed_title><pmcid>PMC7374834</pmcid><funding_grant_id>81671209</funding_grant_id><funding_grant_id>81870972</funding_grant_id><funding_grant_id>81871833</funding_grant_id><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Ling X</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Zhao B</pubmed_authors><pubmed_authors>Hu G</pubmed_authors><pubmed_authors>Deng Z</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhu Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke.</name><description>&lt;h4>Background&lt;/h4>Small extracellular vesicles (sEV) secreted by mesenchymal stem cells (MSC) derived from human induced pluripotent stem cells (iPSC, iMSC-sEV) are considered to have great potential in treating ischemic diseases. Angiogenesis play an important role in post-stroke recovery. However, no studies have yet been conducted to systemically examine the effect and the underlying mechanism of iMSC-sEV on angiogenesis under brain ischemia conditions.&lt;h4>Methods&lt;/h4>Ischemic stroke model was performed in rats induced by middle cerebral artery occlusion (MCAO), and the pro-angiogenic capacity of iMSC-sEV was measured. The in vitro effects of iMSC-sEV on the migration and tube formation of endothelial cells were investigated, respectively. Autophagy and autophagy-related signaling path</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-04T22:32:15.142Z</modification><creation>2025-04-04T22:32:15.142Z</creation></dates><accession>S-EPMC7374834</accession><cross_references><pubmed>32698909</pubmed><doi>10.1186/s13287-020-01834-0</doi></cross_references></HashMap>